Gracell Biotechnologies Inc. American Depositary Shares
GRCL
GRCL was delisted on the 21st of February, 2024.
32 hedge funds and large institutions have $176M invested in Gracell Biotechnologies Inc. American Depositary Shares in 2022 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 10 reducing their positions, and 8 closing their positions.
134% more capital invested
Capital invested by funds: $75.1M → $176M (+$101M)
6% less funds holding
Funds holding: 34 → 32 (-2)
25% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 8
40% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CII
Capital International Inc
Los Angeles,
California
|
+$2.05M |
| 2 |
EC
EcoR1 Capital
San Francisco,
California
|
+$1.12M |
| 3 |
SSA
Schonfeld Strategic Advisors
New York
|
+$802K |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
+$272K |
| 5 |
BlackRock
New York
|
+$263K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$2.33M |
| 2 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
-$1.04M |
| 3 |
SG Americas Securities
New York
|
-$503K |
| 4 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$257K |
| 5 |
Goldman Sachs
New York
|
-$249K |
GRCL Hedge Fund Activity: Q2 2022 in Review
32 of the 5,791 institutional investors tracked by Wall St. Rank reported a position in Gracell Biotechnologies Inc. American Depositary Shares (GRCL) for Q2 2022, worth a combined $176M — up 134% from $75.1M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of GRCL and 6 opened new positions — a net loss of 2 holders — while 10 trimmed existing stakes and 6 added.
The largest buyer was Capital International Inc, adding an estimated $2.05M. The largest seller was Wellington Management Group, cutting an estimated $2.33M.
- 32 institutional investors held Gracell Biotechnologies Inc. American Depositary Shares (GRCL) as of Q2 2022, down from 34 in Q1 2022.
- Funds reported $176M of Gracell Biotechnologies Inc. American Depositary Shares stock for Q2 2022, up 134% quarter-over-quarter.
- 6 funds opened new Gracell Biotechnologies Inc. American Depositary Shares positions in Q2 2022 and 8 closed out, a net change of -2 holders.
- The largest Gracell Biotechnologies Inc. American Depositary Shares buyer in Q2 2022 was Capital International Inc, an estimated $2.05M added.
- The largest Gracell Biotechnologies Inc. American Depositary Shares seller in Q2 2022 was Wellington Management Group, an estimated $2.33M sold.
Based on aggregated 13F filings for Q2 2022.